[1]
“Combination of Sofosburvir and Daclatsvir in the treatment of Hepatitis C Genotype 2 and Genotype 3”, mfm, vol. 32, no. 4, May 2021, Accessed: Apr. 16, 2026. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/1915